Quanterix announced after the close of the market on Wednesday that it has inked an agreement to acquire privately held UmanDiagnostics for $22.5 million.

Illumina has filed patent infringement suits in the US, Switzerland, and Turkey relating to BGI's sequencing instrumentation and chemistry, the company said today.

The global point of care (POC) diagnostics/testing market size is expected to grow at a CAGR of 3.3% over the forecast period 2019-2025 to reach USD 22.8 billion by 2025...

Thermo Fisher Scientific said today that it has acquired HighChem, a developer of mass spectrometry software based in Slovakia.

The global blood gas analyzers market was valued at USD 594.6 million in 2017 and is projected to grow at a CAGR of 5.5% over the forecast period (2018 – 2026) to surpass USD 940 million by 2026.

The global blood coagulation analyzer market is projected to grow at a substantial CAGR of 5.9% over the period 2018 to 2023, driven by its increasing scope, product types, and applications.

Bio-Techne today announced that it has received a clinical laboratory permit from the New York State Department of Health to provide its liquid biopsy-based ExoDx Prostate IntelliScore (EPI) test in the state.

Beckman Coulter Life Sciences said today it has acquired single-cell data analysis and software-as-a-service company Cytobank for an undisclosed amount.

Resolution Bioscience is the latest in a long line of firms that has been granted breakthrough device designation from FDA. The Kirkland, WA-based company received the designation for its qualitative in vitro diagnostic...

A breach of Quest Diagnostics’ billing collections vendor could have exposed the personal, financial, and medical information of as many as 12 million customers, multiple media outlets are reporting.

There’s a new player in the liquid biopsy field. Thrive Earlier Detection Corp., announced late last month that it has launched and has raised $110 million in its Series A round.

Inivata has developed the InVision platform based on research from the Cancer Research UK Cambridge Institute at the University of Cambridge. Its lead product, InVisionFirst-Lung, is commercially available and was develo..

?The latest bit of activity comes from Saga Diagnostics, a Lund, Sweden based company that has raised $4.1 million in a financing round.

Liquid biopsy has attracted a surge of companies that are trying to change the way cancer is detected and monitored.

Upon closing of the transaction, Burlington, the MA-based company will be a subsidiary of Bracco Imaging, led by its current leadership team.